ÂÜÀòÂÒÂ×

Currently Investment Director of Inveready’s Biotechnology Fund, where she screens, invests and manages investments in Drug Development, Molecular Diagnostics, Nutraceuticals and Medical Devices. Previously, was Director of Spin-outs for the University of Barcelona, where she helped launch and finance over 25 start-ups and negotiated numerous technology licenses. Prior experience includes working as an analyst for Chevron Technology Ventures, the Corporate Venture Capital Fund of the US’s second largest integrated oil company, with US 210 Million under management, where she was involved in investing and successfully exiting energy-related technology start-ups. Also worked for Dames and Moore (now URS Corp), the environmental consultancy firm, in the US, Canada and Latin America as well as the World Bank and the International Finance Corporation. Sara holds a BS in Chemistry from the University of Barcelona, a Master’s in Environmental Science from Indiana University, and an MBA from the London Business School.